这是医业观察的第2115-5期文章
来源:360Dx、体外诊断观察翻译整理
DermTech是一家位于美国加利福尼亚州拉霍亚市的分子基因组学公司,专注于开发和销售用于诊断皮肤癌和相关疾病的非侵入性诊断测试。该公司利用其专有的qPCR检测方法,对非侵入性皮肤样本进行活检,...查看全文
DermTech(DMTK)05-18 04:15
$DermTech(DMTK)$ 8-K Current report, items 2.04 and 8.01 Accession Number: 0001651944-24-000049 Act: 34 Size: 148 KB 网页链接查看全文
DermTech(DMTK)05-15 04:15
$DermTech(DMTK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001651944-24-000044 Act: 34 Size: 251 KB 网页链接查看全文
DermTech(DMTK)05-15 18:15
$DermTech(DMTK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001651944-24-000047 Act: 34 Size: 4 MB 网页链接查看全文
DermTech(DMTK)06-18 20:15
$DermTech(DMTK)$ 8-K Current report, items 1.03, 2.05, 5.02, 8.01, and 9.01 Accession Number: 0001651944-24-000060 Act: 34 Size: 191 KB 网页链接查看全文
DermTech(DMTK)05-11 04:15
$DermTech(DMTK)$ 8-K Current report, item 2.04 Accession Number: 0001651944-24-000039 Act: 34 Size: 149 KB 网页链接查看全文
DermTech(DMTK)06-08 08:15
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001651944-24-000053 Size: 6 KB 网页链接查看全文
DermTech(DMTK)04-27 04:05
$DermTech(DMTK)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001651944-24-000035 Act: 34 Size: 788 KB 网页链接查看全文
DermTech(DMTK)06-21 04:05
$DermTech(DMTK)$ 8-K Current report, item 3.01 Accession Number: 0001651944-24-000063 Act: 34 Size: 147 KB 网页链接查看全文
DermTech(DMTK)06-13 08:15
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001651944-24-000055 Size: 4 KB 网页链接查看全文
医业观察星哥04-20 23:25
有观点,有态度
这是医业观察的第2115-5期文章
来源:360Dx、体外诊断观察翻译整理
DermTech是一家位于美国加利福尼亚州拉霍亚市的分子基因组学公司,专注于开发和销售用于诊断皮肤癌和相关疾病的非侵入性诊断测试。该公司利用其专有的qPCR检测方法,对非侵入性皮肤样本进行活检,...查看全文
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-045959 Size: 6 KB 网页链接
$DermTech(DMTK)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001564590-21-036001 Act: 34 Size: 5 MB 网页链接
$DermTech(DMTK)$ 内部交易: 2021-07-01,CEO,Dobak John ,卖出,12500普通股, $41.08
$DermTech(DMTK)$ 内部交易: 2021-06-30,Director,PANCOAST SCOTT R ,卖出,5000普通股, $42.41
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-045203 Size: 7 KB 网页链接
$DermTech(DMTK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-045204 Size: 8 KB 网页链接
$DermTech(DMTK)$ 内部交易: 2021-06-11,CEO,Dobak John ,卖出,7651普通股, $41.08
$DermTech(DMTK)$ 内部交易: 2021-06-11,CFO,Sun Kevin M ,卖出,1933普通股, $41.08
$DermTech(DMTK)$ 内部交易: 2021-06-14,Chief Commercial Officer,Wood Todd Michael ,卖出,2590普通股, $41.44
$DermTech(DMTK)$ 内部交易: 2021-06-11,Chief Commercial Officer,Wood Todd Michael ,卖出,2193普通股, $41.19